References
- Badger AM, Lee JC (1997): Advances in antiarthritic therapeutics. Drug Discovery Today 2: 427–435.
- Conway JG, Wakefield JA, Brown RH, Marron BE, Sekut L, Stimpson SA, McElroy A, Menius JA, Jeffreys JJ, Clark RL, Gerard M McGeehan, Connollyll KM (1995): Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. J Exp Med 182: 449–457.
- Goldenberg MM, Ilse AC (1977): Anti-inflammatory activity of EU-2972. Arch Int Pharmacodynamics 228: 153–161.
- Khanna D, Sethi G, Ahn KS, Pandey MK, Kunnumakkara A B, Sung B, Aggarwal A, Aggarwal BB (2007): Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol 7: 344–351.
- Kirtikar KR, Basu BD (1999): Indian Medicinal Plants, Vol. III, Dehradun, International Book Distributors, p. 2155.
- Nadkarni KM (2000). Indian Materia Medica. Vol. I, Mumbai, Popular Prakashan, p. 759.
- Nantel F, Denis D, Gordon R, Northey A, Cirino M., Metters KM, Chan CC (1999): Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. Braz J Pharmacol 128: 853–859.
- Newbould BB (1963): Chemotherapy of arthritis induced in rats by mycobacterial adjuvant. Brit J Pharmacol 21: 127–136.
- Noguchi M, Kimoto A, Kobayashi S, Yoshino T, Miyata K, Sasamata M (2005): Effect of celecoxib, a cyclooxygenase-2-inhibitor, on pathophysiology of adjuvant induced arthritis in rat. Eur J Pharmacol 513: 229–235.
- OECD (Organization of Economic Co-operation Development) (2001): The OECD Guideline for Testing of Chemical: 420 Acute Oral Toxicity. OECD, Paris, pp. 1–14.
- Pearson CM, Wood FD (1959): Studies on polyarthritis and other lesions induced in rats by the injection of mycobacterial adjuvant: I. General clinical and pathological characteristics and some modifying factors. Arth Rheum 2: 440–459.
- Singh S, Majumdar DK (1996): Effect of fixed oil of Ocimum sanctum against experimentally induced arthritis and joint edema in laboratory animals. Int J Pharmacog 34: 218–222.
- Spector WG (1960): The inflammatory response. J Path Bact 84: 391–403.
- Ueno A, Naraba H, Ikeda Y, Ushikubi F, Murata T, Naramiya S, Ohishi S (2000): Intrinsic prostacyclin contributes to exudation induced by bradikinin or carrageenan: A study on the paw edema induced in ip-receptor-deficient mice. Life Science 66: 155–160.
- Vogel GH (2002): Drug Discovery and Evaluation: Pharmacological Assays, Berlin, Heidelberg, New York, Springer, pp. 696, 802–803.
- Winter CA, Risley EA, Nuss GW (1962): Carrageenan-induced edema in hind paw of the rats as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111: 544–554.